$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
09:47am, Monday, 27'th Nov 2023
Investors are increasingly optimistic about Labcorp (LH) due to development in targeted high-growth areas.
Labcorp (LH) Closes the Legacy Health Asset Acquisition Deal
09:03am, Friday, 24'th Nov 2023
Labcorp (LH) finalizes the comprehensive laboratory relationship with Legacy Health.
Labcorp (LH) Q3 Earnings and Revenues Beat, Margins Fall
12:02pm, Thursday, 26'th Oct 2023
Labcorp (LH) delivers a strong performance in the third quarter of 2023 across the Diagnostics Laboratories and Biopharma Laboratory Services businesses.
Here's What Key Metrics Tell Us About Labcorp (LH) Q3 Earnings
10:32am, Thursday, 26'th Oct 2023
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Stree
Labcorp (LH) Surpasses Q3 Earnings and Revenue Estimates
09:48am, Thursday, 26'th Oct 2023
Labcorp (LH) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.37 per share. This compares to earnings of $4.68 per share a year ago.
Labcorp beats quarterly profit estimates on strength in routine testing segment
08:09am, Thursday, 26'th Oct 2023
Laboratory Corporation of America topped Wall Street expectations for quarterly adjusted profit on Thursday, as strength in its routine diagnostics business more than offset weak COVID test sales.
Labcorp (LH) Launches Biomarker Test for Alzheimer's Disease
09:46am, Friday, 13'th Oct 2023
Labcorp's (LH) new test, ATN Profile, is likely to accelerate the path to the diagnosis of Alzheimer's disease.
Labcorp launches 3-part blood test for Alzheimer's
07:34am, Wednesday, 11'th Oct 2023
Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's, accelerating diagnosis of the brain-wasting disea
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
06:57am, Friday, 29'th Sep 2023
BURLINGTON, N.C. , Sept. 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
10:32am, Thursday, 28'th Sep 2023
Investors are increasingly optimistic about Labcorp (LH) due to its progress in hospital partnerships.
LabCorp (LH) Suffers From Lower COVID Test Sales, Macro Woes
12:02pm, Monday, 28'th Aug 2023
Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues.
The 7 Most Undervalued Value Stocks to Buy Now: August 2023
09:26pm, Thursday, 17'th Aug 2023
While the glitz and glamour of the hottest technology firms organically command our attention, investors should earmark some time for researching value stocks to buy. Fundamentally, these under-the-ra
3 MedTech Stocks Likely to Top Estimates This Earnings Season
09:45am, Thursday, 03'rd Aug 2023
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.
LabCorp (LH) Q2 Earnings Miss Estimates, Margins Decline
02:43pm, Thursday, 27'th Jul 2023
A rise in organic revenues, acquisitions, net of divestitures and foreign currency translation drive LabCorp's (LH) Q2 revenues.
Laboratory Corporation of America Holdings (LH) Q2 2023 Earnings Call Transcript
01:47pm, Thursday, 27'th Jul 2023
Laboratory Corporation of America Holdings (NYSE:LH ) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Chas Cook – Vice President-Investor Relations Adam Schechter –
Sign In
Buy LH